Steris recalled 22 AMSCO 7053HP Washer/Disinfectors on November 19, 2025, due to a risk of electrical arcing. The issue arises from a wire connected to the electrical box that may shift from its intended position. Users must stop using the device immediately and follow recall instructions.
Wire connected to the electrical box may shift out of its intended position, which may result in electrical arcing. Electrical arcing remains internal within the unit (no risk of shock to users).
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Steris Corporation or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled AMSCO 7053HP Washer/Disinfector is designed for cleaning and disinfecting hard-surfaced surgical instruments and similar items. The affected model number is 7053HP, with lot codes including UDI: 00724995176662 and various serial numbers. These units were distributed worldwide, including states across the U.S. and Australia.
The wire connected to the electrical box can shift, leading to potential electrical arcing. This arcing remains contained within the unit, posing no shock risk to users but could lead to equipment malfunction.
No injuries or incidents have been reported in connection with this recall. The defect poses a high hazard level, classified as Class II by the FDA.
Stop using the AMSCO 7053HP Washer/Disinfector immediately. Contact Steris Corporation or your healthcare provider for further instructions. Follow the recall notification letter for detailed actions.
For more information, contact Steris Corporation at their official website or call their customer service.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.